DHP sibr PH II #OSD11-H10
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH15C0080
- Awardee
-
Stratatech Corporation UEI WE88ZJ5AY3F9
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $999,957
Award facts
- Opportunity
-
- W81XWH11RAAA1 Solicitation number
- Contract value 100% obligated
- $999,957.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Madison, WI 53719, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $999,957 |
About this award
This federal contract award, identified as W81XWH15C0080, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense (DOD) to Stratatech Corporation, a foreign-owned, for-profit company. The $999,957.14 cost-plus-fixed-fee contract was awarded on September 30, 2015 with a completion date of February 28, 2019. The contract was set aside for small businesses.
Stratatech Corporation is a subsidiary of Mallinckrodt Plc and has been registered in SAM.gov since 2005 to receive federal contract and grant awards. The company has previously received grant funding for the development of advanced regenerative medicine and tissue engineering products. This contract award appears to be related to Stratatech's work in these areas, though the specific products or services being delivered are not detailed in the information provided.
The contract is also associated with a larger Indefinite Delivery Vehicle (IDV) contract that Stratatech holds with the Department of Veterans Affairs (VA) to provide pharmaceuticals, drugs, and hematology-related products to VA medical facilities within the VA's Network 12 region. This multiple-award schedule contract has a potential value of $850,000 and runs through March 2027.
Quick answers
Who was awarded contract W81XWH15C0080?
W81XWH15C0080 was awarded to Stratatech Corporation by Medical Command (Department of the Army) on September 30, 2015.
How much is contract W81XWH15C0080 worth?
The government has obligated $999,957 on W81XWH15C0080.
Was contract W81XWH15C0080 competed?
The extent of competition for W81XWH15C0080 was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award